Events
ESMO 2025: New generation of antibody-drug conjugates shows promise in early-stage disease
- ESMO 2025: Novel treatment combination improves progression-free survival in metastatic, oestrogen-receptor-positive HER-2-negative breast cancer
- NCCN Guidelines Navigator for breast cancer genetic testing and treatment
- Could reducing inflammation help combat fatigue in people with early-stage breast cancer?
The OJC Episode 61: New Dimensions in the Hallmarks of Cancer
Join Eva Segelov, Craig Underhill and Hans Prenen as they chat through the latest papers. In today’s episode Eva talks…
How cancer cells move and metastasize is influenced by the fluids surrounding them – understanding how tumours migrate can help stop their spread
Yizeng Li, Binghamton University, State University of New York Cell migration, or how cells move in the body, is essential…









